Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Allogeneic Granulocyte Infusion in the Treatment of Patients With Advanced Cancer

NCT04124666 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT04124666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04124666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Allogeneic Granulocyte Infusion in the Treatment of Patients With Advanced Cancer
Lead sponsor
Shanghai East Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 1, 2019
Completion date
September 30, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer